Prognostic value of pre- and post-transplantation <sup>18</sup>F-fluorodeoxyglucose positron emission tomography results in non-Hodgkin lymphoma patients receiving autologous stem cell transplantation.
| Author | |
|---|---|
| Abstract |
:
High-dose chemotherapy (HDC) followed by autologous stem cell transplantation (ASCT) is the standard of care in the upfront or relapsed/refractory setting in some patients with non-Hodgkin lymphoma (NHL). However, a proportion of patients do not respond to ASCT. 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) has been widely used for staging, response evaluation, and prognosis prediction. Here, we investigated the prognostic role of PET/CT in NHL patients before and after ASCT. |
| Year of Publication |
:
2017
|
| Journal |
:
Chinese journal of cancer research = Chung-kuo yen cheng yen chiu
|
| Volume |
:
29
|
| Issue |
:
6
|
| Number of Pages |
:
561-571
|
| ISSN Number |
:
1000-9604
|
| URL |
:
http://dx.doi.org/10.21147/j.issn.1000-9604.2017.06.11
|
| DOI |
:
10.21147/j.issn.1000-9604.2017.06.11
|
| Short Title |
:
Chin J Cancer Res
|
| Download citation |
